Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer

NCT02274779 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: ELIGARD

Sponsor

Institut Cancerologie de l'Ouest

Collaborators

[object Object]